Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Self · BECTON DICKINSON & CO · Becton, Dickinson and Company Common Stock
Purchase
Disclosed range starting at $1K
Disclosed 116 days after execution (STOCK Act deadline: 45)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | THOMAS POLENDirector, Chairman, CEO and President | Disposition to issuer · 10b5-1 plan | D | $3.62M 17.2K sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 12 | THOMAS POLENDirector, Chairman, CEO and President | Option exercise · 10b5-1 plan | M | $3.62M 20.2K sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 16 | THOMAS POLENDirector, Chairman, CEO and President | Open-market sale · 10b5-1 plan | SELL | $629K 2,993 sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 0 | THOMAS POLENDirector, Chairman, CEO and President | Option exercise · 10b5-1 plan | M | — 20.2K sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 6 | Feld MichaelEVP, Chief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $15K 76 sh | Oct 27, 2026 traded Oct 26, 2026 | |
| 1 | Feld MichaelEVP, Chief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $14K 76 sh | Sep 29, 2026 traded Sep 28, 2026 | |
| 5 | Feld MichaelEVP, Chief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $11K 75 sh | Jun 26, 2026 traded Jun 26, 2026 | |
| 20 | Thomas H. Kean, Jr.RSelf | Sale | SELL | $1,001 – $15K | Jun 18, 2026 traded May 21, 2026 | |
| 24 | Kevin HernRJoint | Sale | SELL | $15K – $50K | Apr 3, 2026 traded Mar 17, 2026 | |
| 9 | Spikner Pamela L.SVP Controller & CAO | Tax withholding | F | — 84 sh | Jan 23, 2026 traded Jan 21, 2026 | |
| 13 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Disposition to issuer · 10b5-1 plan | D | $513K 2,454 sh | Jan 16, 2026 traded Jan 15, 2026 | |
| 12 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Open-market sale · 10b5-1 plan | SELL | $209K 1,010 sh | Jan 16, 2026 traded Jan 15, 2026 | |
| 0 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Option exercise · 10b5-1 plan | M | — 3,054 sh | Jan 16, 2026 traded Jan 15, 2026 | |
| 8 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Open-market sale · 10b5-1 plan | SELL | $125K 600 sh | Jan 16, 2026 traded Jan 15, 2026 | |
| 13 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Option exercise · 10b5-1 plan | M | $513K 3,054 sh | Jan 16, 2026 traded Jan 15, 2026 | |
| 9 | Shan DavidEVP and Chief ISC Officer | Tax withholding | F | — 44 sh | Jan 6, 2026 traded Jan 3, 2026 | |
| 21 | Scott Bertram LDirector | Open-market sale | SELL | $38K 217 sh | Nov 7, 2025 traded Nov 7, 2025 |
Read directly from the primary public document; every field below is as reported by the filer.
Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.
= $8,001
Alan Armstrong reported a purchase of Becton, Dickinson and Company Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.
Recorded votes from the House Clerk and Voteview (Senate). Listed by date; a vote near a trade is not evidence the two are related.